🇺🇸 FDA
Pipeline program

BHV-7000, Placebo for BHV-7000, BHV-7000

BHV7000-304

Phase 3 small_molecule active

Quick answer

BHV-7000, Placebo for BHV-7000, BHV-7000 for Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures is a Phase 3 program (small_molecule) at Biohaven Bioscience Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Biohaven Bioscience Ireland Limited
Indication
Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials